DEPO-TESTADIOL Drug Patent Profile
✉ Email this page to a colleague
When do Depo-testadiol patents expire, and what generic alternatives are available?
Depo-testadiol is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in DEPO-TESTADIOL is estradiol cypionate; testosterone cypionate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol cypionate; testosterone cypionate profile page.
US Patents and Regulatory Information for DEPO-TESTADIOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | DEPO-TESTADIOL | estradiol cypionate; testosterone cypionate | INJECTABLE;INJECTION | 017968-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
